Citi Pharma Limited (PSX:CPHL)
Pakistan · Delayed Price · Currency is PKR 85.06
+0.86 (1.02%)
At close: Jan 16, 2026
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 19.24 billion as of January 16, 2026. Its market cap has increased by 23.62% in one year.
Market Cap
19.24B
Enterprise Value
21.13B
Revenue
13.30B
Ranking
n/a
PE Ratio
21.53
Stock Price
85.06
Market Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 19.24B, an increase of 169.24%. That is a compound annual growth rate of 24.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 19.24B | -0.47% |
| Dec 31, 2025 | 19.33B | 24.21% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
| Jul 9, 2021 | 7.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 132.85B |
| Abbott Laboratories (Pakistan) | 117.45B |
| The Searle Company | 72.73B |
| AGP Limited | 60.24B |
| Highnoon Laboratories | 54.28B |
| Shifa International Hospitals | 34.77B |
| Ferozsons Laboratories | 17.82B |
| Macter International | 15.24B |